左心室辅助装置作为晚期心力衰竭终末替代治疗的研究进展  

Left Ventricular Assist Device as Destination Therapy in End-stage Heart Failure

作　　者：张颖 周建中[2] 徐俊波[1] ZHANG Ying;ZHOU Jianzhong;XU Junbo(Department of Cardiology,The Third People's Hospital of Chengdu,Chengdu 610031,Sichuan,China;Department of Cardiology,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)

机构地区：[1]成都市第三人民医院心血管内科,四川成都610031 [2]重庆医科大学附属第一医院心血管内科,重庆400016

出　　处：《心血管病学进展》2020年第9期958-961,共4页Advances in Cardiovascular Diseases

基　　金：成都市技术创新研发项目(2019-YF05-00523-SN)。

摘　　要：心力衰竭已成为一个全球性问题,其发病率和患病率正以惊人的速度增加。尽管规范化的药物治疗和心脏再同步化治疗等器械治疗可缓解部分患者的症状,但仍有大量患者对此疗效不佳。对于这些患者可进行心脏移植治疗,但目前中国心脏移植在临床应用非常有限;而左心室辅助装置为这些患者提供了一种较理想的替代治疗方案,现就左心室辅助装置作为晚期心力衰竭患者终末替代治疗的研究进展进行综述。Heart failure has become a global problem,and its incidence and prevalence are increasing at an alarming rate.Some heart failure patients respond poorly to standard guideline medical therapy and devices such as cardiac resynchronization therapy.For these patients,heart transplantation can be performed,but the current clinical application of heart transplantation in China is very limited.Left ventricular assist device provides as an ideal destination therapy for these patients.This review makes a summary on recent progress of left ventricular assist device as destination therapy.

关 键 词：心力衰竭 左心室辅助装置 终末替代治疗 

分 类 号：R541.6[医药卫生—心血管疾病]